Literature DB >> 15368294

Cdk2 activation acts upstream of the mitochondrion during glucocorticoid induced thymocyte apoptosis.

Francesc Granés1, Maurici B Roig, Hugh J M Brady, Gabriel Gil-Gómez.   

Abstract

Thymocytes undergo apoptosis during negative selection in vivo and following treatment with glucocorticoids or DNA-damaging drugs in vitro. The post-mitochondrial biochemical steps leading to apoptosis induced by these stimuli are well characterized, however, much less is known about the pathways connecting receptor triggering, apical caspase activation and induction of mitochondrial dysfunction. These stimuli specifically activate the kinase Cdk2 and this step is obligatory for these forms of thymocyte apoptosis. We report here that Cdk2 activation is a very early step during thymocyte apoptosis preceding apical caspase activation and phosphatidylserine exposure. Furthermore, Cdk2 activation is required for mitochondrial permeability disruption, cytochrome c release and, as a consequence, activation of the downstream caspases 9 and 3. Our data allow an integrated linear pathway regulating DNA damage and glucocorticoid-induced thymocyte apoptosis to be proposed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368294     DOI: 10.1002/eji.200425154

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2.

Authors:  Cyril Berthet; Maria Cecilia Rodriguez-Galan; Deborah L Hodge; John Gooya; Véronique Pascal; Howard A Young; Jonathan Keller; Remy Bosselut; Philipp Kaldis
Journal:  Mol Cell Biol       Date:  2007-05-07       Impact factor: 4.272

2.  Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis.

Authors:  Rachel Spokoini; Shlomit Kfir-Erenfeld; Eitan Yefenof; Ronit Vogt Sionov
Journal:  Mol Endocrinol       Date:  2010-04-06

3.  Coupling of the cell cycle and apoptotic machineries in developing T cells.

Authors:  Ling Xue; Yuefang Sun; Leslie Chiang; Bo He; Chulho Kang; Hector Nolla; Astar Winoto
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

4.  Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy.

Authors:  Liguo Wang; Xuejing Shao; Tianbai Zhong; Yue Wu; Aixiao Xu; Xiuyun Sun; Hongying Gao; Yongbo Liu; Tianlong Lan; Yan Tong; Xue Tao; Wenxin Du; Wei Wang; Yingqian Chen; Ting Li; Xianbin Meng; Haiteng Deng; Bo Yang; Qiaojun He; Meidan Ying; Yu Rao
Journal:  Nat Chem Biol       Date:  2021-03-04       Impact factor: 15.040

5.  Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis.

Authors:  Ronit Vogt Sionov; Orly Cohen; Shlomit Kfir; Yael Zilberman; Eitan Yefenof
Journal:  J Exp Med       Date:  2006-01-03       Impact factor: 14.307

6.  Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells.

Authors:  Ajay Palagani; Ken Op de Beeck; Stefan Naulaerts; Jolien Diddens; Chandra Sekhar Chirumamilla; Guy Van Camp; Kris Laukens; Karen Heyninck; Sarah Gerlo; Pieter Mestdagh; Joke Vandesompele; Wim Vanden Berghe
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

7.  The regulation of the mitochondrial apoptotic pathway by glucocorticoid receptor in collaboration with Bcl-2 family proteins in developing T cells.

Authors:  Lilla Prenek; Ferenc Boldizsár; Réka Kugyelka; Emese Ugor; Gergely Berta; Péter Németh; Timea Berki
Journal:  Apoptosis       Date:  2017-02       Impact factor: 4.677

8.  CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss.

Authors:  Tal Teitz; Jie Fang; Asli N Goktug; Justine D Bonga; Shiyong Diao; Robert A Hazlitt; Luigi Iconaru; Marie Morfouace; Duane Currier; Yinmei Zhou; Robyn A Umans; Michael R Taylor; Cheng Cheng; Jaeki Min; Burgess Freeman; Junmin Peng; Martine F Roussel; Richard Kriwacki; R Kiplin Guy; Taosheng Chen; Jian Zuo
Journal:  J Exp Med       Date:  2018-03-07       Impact factor: 14.307

9.  Constitutive Cyclin O deficiency results in penetrant hydrocephalus, impaired growth and infertility.

Authors:  Marc Núnez-Ollé; Carole Jung; Berta Terré; Norman A Balsiger; Cristina Plata; Ramon Roset; Carlos Pardo-Pastor; Marta Garrido; Santiago Rojas; Francesc Alameda; Josep Lloreta; Juan Martín-Caballero; Juana M Flores; Travis H Stracker; Miguel A Valverde; Francisco J Muñoz; Gabriel Gil-Gómez
Journal:  Oncotarget       Date:  2017-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.